Sinovac Biotech Co., Ltd: Poliomyelitis trials

The registry lists 15 Poliomyelitis studies with Sinovac Biotech Co., Ltd as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 6Phase 4 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus VaccineRecruitingNCT07457060Phase 4
• Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsRecruitingNCT07354269Phase 4
• Booster Dose of sIPV Co-administered With MMR and HepA-I.CompletedNCT06442449Phase 4
• Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different ManufacturersCompletedNCT06346834Phase 4
• Immunogenicity of After Primary Immunization and Booster Immunization of sIPVActive, not recruitingNCT06058429
• A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV VaccineCompletedNCT05850364Phase 3
• A Safety Study of Sabin Inactivated Poliovirus Vaccine in InfantsCompletedNCT05432141Phase 4
• Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old InfantsCompletedNCT05386810Phase 3
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four DosesCompletedNCT04989231
• Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine ImmunizationCompletedNCT04618783Not applicable
• Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio VaccineCompletedNCT04386707Phase 3
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in InfantsCompletedNCT03822767Phase 3
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in InfantsCompletedNCT03822754Phase 3
• An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old InfantsCompletedNCT03526978Phase 3
• Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus VaccineCompletedNCT02985320Phase 1/2